PALI
Palisade Bio Inc

19,591
Mkt Cap
$238.41M
Volume
2.26M
52W High
$2.64
52W Low
$0.53
PE Ratio
-0.38
PALI Fundamentals
Price
$1.60
Prev Close
$1.63
Open
$1.66
50D MA
$1.86
Beta
1.08
Avg. Volume
5.97M
EPS (Annual)
-$10.19
P/B
4.55
Rev/Employee
$0.00
$7.31
Loading...
Loading...
News
all
press releases
Palisade Bio, Inc. (NASDAQ:PALI) Given Consensus Recommendation of "Moderate Buy" by Analysts
Palisade Bio, Inc. (NASDAQ:PALI - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six research firms that are currently covering the company, MarketBeat reports. One...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
Palisade Bio, Inc. (NASDAQ:PALI) Sees Large Increase in Short Interest
Palisade Bio, Inc. (NASDAQ:PALI - Get Free Report) saw a large growth in short interest during the month of January. As of January 30th, there was short interest totaling 21,095,322 shares, a growth...
MarketBeat·4d ago
News Placeholder
Palisade Bio (NASDAQ:PALI) Lowered to Sell Rating by Wall Street Zen
Wall Street Zen lowered Palisade Bio from a "hold" rating to a "sell" rating in a research report on Saturday...
MarketBeat·15d ago
News Placeholder
Palisade Bio, Inc. (NASDAQ:PALI) Receives Average Rating of "Moderate Buy" from Brokerages
Palisade Bio, Inc. (NASDAQ:PALI - Get Free Report) has received an average recommendation of "Moderate Buy" from the six research firms that are currently covering the stock, MarketBeat reports. One...
MarketBeat·27d ago
News Placeholder
Palisade Bio, Inc. (NASDAQ:PALI) Short Interest Up 24.4% in December
Palisade Bio, Inc. (NASDAQ:PALI - Get Free Report) was the target of a large increase in short interest during the month of December. As of December 31st, there was short interest totaling 15,949,282...
MarketBeat·1mo ago
News Placeholder
Wall Street Zen Upgrades Palisade Bio (NASDAQ:PALI) to "Hold"
Wall Street Zen raised shares of Palisade Bio from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·2mo ago
News Placeholder
Palisade Bio, Inc. (NASDAQ:PALI) Receives Consensus Rating of "Moderate Buy" from Analysts
Shares of Palisade Bio, Inc. (NASDAQ:PALI - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five brokerages that are presently covering the company, Marketbeat.com...
MarketBeat·2mo ago
News Placeholder
Palisade Bio (NASDAQ:PALI) Stock Rating Upgraded by Clear Str
Clear Str raised shares of Palisade Bio to a "strong-buy" rating in a report on Monday...
MarketBeat·2mo ago
News Placeholder
Palisade Bio (NASDAQ:PALI) Upgraded at Piper Sandler
Piper Sandler upgraded shares of Palisade Bio to a "strong-buy" rating in a report on Monday...
MarketBeat·2mo ago
News Placeholder
Palisade Bio (NASDAQ:PALI) Stock Rating Lowered by Wall Street Zen
Wall Street Zen downgraded Palisade Bio from a "hold" rating to a "sell" rating in a research note on Saturday...
MarketBeat·2mo ago
<
1
2
...
>

Latest PALI News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.